November 6, 2017—BTG International advised that the Centers for Medicare & Medicaid Services published the final fee schedule for new category I CPT codes for the company's Varithena procedures. The codes become effective on January 1, 2018.
The fee schedule details payments for conducting Varithena treatments in the physician office setting of $1,624.30 for a single vein and $1,697.02 for multiple veins. The new CPT codes define Medicare payment rates and enable automatic and electronic processing of claims. This will provide physicians in the United States with additional predictability of payments and streamlining of the reimbursement process, stated BTG.
advertisement
Sponsored by EKOS Corporation
Related Articles
Top 5 Articles From October 2017
Ensuring a Good Death: Pain Management and Palliative Procedures in the Oncology Patient
Examining the role of the interventional radiologist in providing end-of-life care.
By Joshua D. Kuban, MD; and Alda Tam, MD
Treating Peripheral Artery Disease in the Popliteal Artery: DA + DCB Versus DCB Alone
By Konstantinos Stavroulakis, MD
Locoregional Management Pathways for Liver Cancer
A practical approach to treating tumors in the liver caused by primary liver cancer, colorectal cancer, and neuroendocrine tumors.
By Martin Edwards, MD; and Siddharth A. Padia, MD
The Interventional Oncology Clinic: Introduction to the IO Clinical Care Model
Assessing interventional oncology patients in an outpatient clinic setting is essential for providing longitudinal and optimal care.
By Eric A. Wang, MD; Mendi D. Mullis, MBA; and Megan E. Kanable, MHA
Current Considerations on Real-World Evidence Use in FDA Regulatory Submissions
Examples and decision making from the Center for Devices and Radiological Health’s Peripheral Interventional Devices Branch.
By Eleni Whatley and Misti Malone
Top 5 from CIToday's Current Issue
Roundtable Discussion: TAVR in Low-Risk Patients
Experts discuss the significance of recent data and the potential impact on their practice.
With Kentaro Hayashida, MD, PhD, FESC, FACC, FJCS; Robert Ostfeld, MD, MSc, FACC; Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC; Michael J. Reardon, MD; and Steven J. Yakubov, MD, FACC, FSCAI
Looking Ahead
By Azeem Latib, MD
Succeeding in Specialty Independent Care
SymphonySuite and Diamond Select support the entrepreneur.
With Jihad A. Mustapha, MD, FACC, FSCAI; and Fadi Saab, MD, FASE, FACC, FSCAI
Perspectives in TAVR
By Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC; and Samir Kapadia, MD, FACC, FSCAI
Bioprosthetic Valve Fracture During ViV TAVR
A step-by-step practical guide for performing BVF to facilitate ViV TAVR.
